alrizomadlin,pembrolizumab
gilead sciences,ascentage pharmaceuticals,merck
['solid tumor', 'ascent', 'alrizomadlin', 'apg-115', 'pembro', 'ascentage pharma', 'ascentage']
asco 2022 | ascentage pharma releases updated results demonstrating the therapeutic potential of alrizomadlin (apg-115) plus pembrolizumab in patients with solid tumors who progressed on immunotherapies 
Politics around the globe